While progress has been made in treating viral hepatitis some problems are not adequately addressed with current therapies. This includes the challenge of treating both chronic as well as fulminant infections. This chapter provides an overview about current activities in the development of novel therapies for viral hepatitis. The activities in this area are very competitive and dynamic and, therefore, the list of projects and compounds might not be complete or reflect the very latest status of certain projects. However, it is clear that the medical need is being addressed and that novel approaches can be expected that might hopefully strengthen the antiviral armamentarium in the future.
CITATION STYLE
Weber, O. (2008). Drug candidates for the treatment of viral hepatitis. In Comparative Hepatitis (pp. 361–377). Birkhäuser Basel. https://doi.org/10.1007/978-3-7643-8558-3_16
Mendeley helps you to discover research relevant for your work.